Product NDC: | 54868-5124 |
Proprietary Name: | VANIQA |
Non Proprietary Name: | eflornithine hydrochloride |
Active Ingredient(s): | 139 mg/g & nbsp; eflornithine hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-5124 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021145 |
Marketing Category: | NDA |
Start Marketing Date: | 20040726 |
Package NDC: | 54868-5124-0 |
Package Description: | 30 g in 1 TUBE (54868-5124-0) |
NDC Code | 54868-5124-0 |
Proprietary Name | VANIQA |
Package Description | 30 g in 1 TUBE (54868-5124-0) |
Product NDC | 54868-5124 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | eflornithine hydrochloride |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20040726 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | EFLORNITHINE HYDROCHLORIDE |
Strength Number | 139 |
Strength Unit | mg/g |
Pharmaceutical Classes | Antiprotozoal [EPC],Decarboxylase Inhibitor [EPC],Decarboxylase Inhibitors [MoA] |